Timothy Almazan is a Dermatology physician affiliated with Stanford University. OpenAlex indexes 21 publications with 240 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11900 South St Ste 118
Cerritos, CA 907036800
Telephone
562-800-3072Provider last certified this registry record 27 Nov 2024.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year202516 payments
- ABBVIE INC.Program year202516 payments
- Janssen Biotech, Inc.Program year202515 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
31.4%Corticosteroid21.2%Triamcinolone Acetonide92%Fluocinolone Acetonide8%Part D<11 patientsInterleukin-4 Receptor alpha Antagonist8%Dupixent Pen100%Part D≥11 patients+ 1 more class in this area
Sensory organs
24.1%Corticosteroid24.1%Clobetasol Propionate49%Hydrocortisone42%Betamethasone Diprop Augmented9%Part D≥47 patientsAnti-infectives
22.5%Azole Antifungal13.3%Ketoconazole100%Part D≥40 patientsLincosamide Antibacterial3.3%Clindamycin Phosphate100%Part D≥13 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Renumathy Dhanasekaran, MD, PhD
Stanford University
Euan Ashley, MD
Stanford University
Sarah Donaldson, MD
Stanford University
Peter Fitzgerald, MD
Stanford University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”